⌘K
Loading ticker…
As of 2026-08-21, Olema Pharmaceuticals, Inc. Common Stock (OLMA) has a 3-month relative strength percentile of 16 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 45. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.6%, relative volume 0.71×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
OLMA is held by 22 ETFs as of May 2026. Top owner: VTWO at 0.03% weight, $5M notional. Top 3 carry $10M.
Held by 51 ETFs · $159M across latest filings · largest weight 0.66% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.03% | $5M | −0.02 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $3M | — |
| VFMO | 0.10% | $2M | −0.03 pp |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| SBIO | 0.66% | $1M | −0.57 pp |
| CANC | 0.60% | $1M | −0.26 pp |
| VTWV | 0.06% | $722K | −0.04 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $369K | — |
| ONEQ | 0.00% | $310K | — |
| GSSC | 0.03% | $248K | new |
Showing 10 of 22 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OLMA Jan avg: 24.44% median: 3.84% win: 75% σ: 48.74% n: 4 2022-04-12 → 2026-07-31 | OLMA Feb avg: -13.60% median: -10.51% win: 0% σ: 10.93% n: 4 2022-04-12 → 2026-07-31 | OLMA Mar avg: -19.11% median: -14.66% win: 0% σ: 13.17% n: 4 2022-04-12 → 2026-07-31 | OLMA Apr avg: 7.67% median: -3.35% win: 40% σ: 28.30% n: 5 2022-04-12 → 2026-07-31 | OLMA May avg: 1.83% median: 2.33% win: 60% σ: 8.58% n: 5 2022-04-12 → 2026-07-31 | OLMA Jun avg: 20.85% median: 11.78% win: 60% σ: 37.84% n: 5 2022-04-12 → 2026-07-31 | OLMA Jul avg: 16.13% median: 20.66% win: 60% σ: 23.43% n: 5 2022-04-12 → 2026-07-31 | OLMA Aug avg: -6.18% median: -7.54% win: 50% σ: 21.36% n: 4 2022-04-12 → 2026-07-31 (current) | OLMA Sep avg: 18.01% median: 11.43% win: 75% σ: 46.08% n: 4 2022-04-12 → 2026-07-31 | OLMA Oct avg: 8.01% median: 2.09% win: 50% σ: 19.97% n: 4 2022-04-12 → 2026-07-31 | OLMA Nov avg: 46.20% median: -3.63% win: 50% σ: 113.63% n: 4 2022-04-12 → 2026-07-31 | OLMA Dec avg: -17.04% median: -13.18% win: 25% σ: 18.14% n: 4 2022-04-12 → 2026-07-31 |